GHK-Cu
A copper peptide used as part of clinician-guided planning for collagen support, elastin support, antioxidant defense, tissue signaling, skin integrity, hair or scalp support, and soft-tissue quality.
Skin quality and recovery blend
A three-component recovery and tissue-quality profile built around GHK-Cu, BPC-157, and TB-500.
Overview
The GLOW stack adapts the tissue-support and regeneration information into three IPS-aligned peptides: GHK-Cu for collagen, skin integrity, hair or scalp support, and soft-tissue quality; BPC-157 for localized tissue and gut-related recovery context; and TB-500 for cell mobility, tissue remodeling, and broader recovery capacity.
Peptide details
A copper peptide used as part of clinician-guided planning for collagen support, elastin support, antioxidant defense, tissue signaling, skin integrity, hair or scalp support, and soft-tissue quality.
Used as part of clinician-guided planning for localized tissue recovery, tendon and ligament goals, connective tissue, soft tissue, joints, and gut-related recovery context.
Used as part of clinician-guided planning for cell mobility, tissue remodeling, systemic recovery support, mobility, and active-lifestyle recovery capacity.
How It Works
IPS frames this stack as a coordinated tissue-quality and recovery option, not a one-size-fits-all promise. The goal is to determine whether this blend fits the patient’s recovery needs, safety profile, and broader clinical context.
GHK-Cu is the most skin-quality focused component and is used for collagen, skin integrity, hair or scalp support, and soft-tissue quality.
BPC-157 is commonly used as part of clinician-guided planning for tendons, ligaments, joints, soft tissue, connective tissue, and gut-related recovery context.
TB-500 is commonly used as part of clinician-guided planning for cell mobility, tissue remodeling, mobility support, and whole-body recovery capacity.
This belongs inside a care plan that considers diagnosis, rehab, training load, nutrition, sleep, medications, and follow-up.
Process
Review skin, hair or scalp, recovery, connective-tissue, training, procedure, and symptom goals.
Clarify medications, health history, active diagnoses, skin or wound concerns, and whether direct medical care is needed.
If appropriate, your clinician reviews whether this blend fits and what should be monitored.
Follow-up tracks tolerance, recovery markers, skin or tissue goals, function, and whether the plan should change.
Safety & candidacy
IPS reviews medical history, cancer history, active skin or wound concerns, infection concerns, current medications, pregnancy-related factors where applicable, procedure planning, and whether the goal is appropriate for peptide review.
Questions
GHK-Cu supports collagen and tissue-quality information, BPC-157 supports localized recovery context, and TB-500 supports remodeling and broader recovery-capacity information.
No. It may be framed around skin quality, soft-tissue quality, recovery, connective tissue, and active-lifestyle goals, but candidacy requires clinician review.
No. Injuries, wounds, infections, post-surgical concerns, skin lesions, and persistent pain should be evaluated and treated through appropriate medical care.
Why IPS is different
Many consumers encounter products online labeled for research use only, not for human consumption, or laboratory chemicals. Those labels matter because they are not intended for patient care.
A product mixed at home from an online powder and labeled research use only is fundamentally different from care that begins with consultation, provider review, appropriate prescribing, and ongoing clinical guidance.
Annual Membership
12-month IPS members receive access to preferred pricing on eligible peptide programs after consultation and medical review.
Contact
Send your details and IPS can follow up about consultation scheduling and next steps.